IRIDEX
CA - Mountain ViewBiotechnology
Focus: IRIDEX is a specialized ophthalmic laser device company founded in 2003, focused on innovative laser therapies for retinal and glaucoma conditions. The company operates in a niche but clinically important segment of ophthalmology with proprietary MicroPulse technology.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About IRIDEX
AI assessmentNot HiringNo open roles listed right now. Follow IRIDEX to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
MicroPulse Laser Treatment
Stable
Growth
Flagship indication addressing a major cause of vision loss in diabetic patients with non-invasive laser therapy.
MicroPulse TransScleral Laser Therapy
Help build intelligence for IRIDEX
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.